Context-specific regulation of cell survival by a miRNA-controlled BIM rheostat

Knockout of the ubiquitously expressed miRNA-17∼92 cluster in mice produces a lethal developmental lung defect, skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic protein BIM, central to life-death decisions in mammalian cells. To clarify th...

Full description

Saved in:
Bibliographic Details
Published inGenes & development Vol. 33; no. 23-24; pp. 1673 - 1687
Main Authors Labi, Verena, Peng, Siying, Klironomos, Filippos, Munschauer, Mathias, Kastelic, Nicolai, Chakraborty, Tirtha, Schoeler, Katia, Derudder, Emmanuel, Martella, Manuela, Mastrobuoni, Guido, Hernandez-Miranda, Luis R, Lahmann, Ines, Kocks, Christine, Birchmeier, Carmen, Kempa, Stefan, Quintanilla-Martinez de Fend, Leticia, Landthaler, Markus, Rajewsky, Nikolaus, Rajewsky, Klaus
Format Journal Article
LanguageEnglish
Published United States Cold Spring Harbor Laboratory Press 01.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Knockout of the ubiquitously expressed miRNA-17∼92 cluster in mice produces a lethal developmental lung defect, skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic protein BIM, central to life-death decisions in mammalian cells. To clarify the contribution of miR-17∼92:Bim interactions to the complex miR-17∼92 knockout phenotype, we used a system of conditional mutagenesis of the nine 3' UTR miR-17∼92 seed matches. Blocking miR-17∼92:Bim interactions early in development phenocopied the lethal lung phenotype of miR-17∼92 ablation and generated a skeletal kinky tail. In the hematopoietic system, instead of causing the predicted B cell developmental block, it produced a selective inability of B cells to resist cellular stress; and prevented B and T cell hyperplasia caused by haploinsufficiency. Thus, the interaction of miR-17∼92 with a single target is essential for life, and BIM regulation by miRNAs serves as a rheostat controlling cell survival in specific physiological contexts.
Bibliography:Present addresses: 7Beijing IDMO Company Limited, Beijing 100000, China; 8Department of Pediatrics, Charité – University Hospital Berlin, Berlin 13353, Germany; 9Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; 10CRISPR Therapeutics, Cambridge, MA 02139, USA.
ISSN:0890-9369
1549-5477
DOI:10.1101/gad.330134.119